EIF2AK3 and non-small cell lung carcinoma: We measured ERK activity in CuB-treated GR NSCLC cells and found that CuB can decrease phosphorylated ERK (pERK) in a dose-dependent manner, without causing clear changes in the total ERK expression in H1975 and H820 cells (Figure 3F).